These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 21106240

  • 21. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation.
    Shutoh M, Oue N, Aung PP, Noguchi T, Kuraoka K, Nakayama H, Kawahara K, Yasui W.
    Cancer; 2005 Oct 15; 104(8):1609-19. PubMed ID: 16134180
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers.
    Takahashi Y, Miyoshi Y, Takahata C, Irahara N, Taguchi T, Tamaki Y, Noguchi S.
    Clin Cancer Res; 2005 Feb 15; 11(4):1380-5. PubMed ID: 15746036
    [Abstract] [Full Text] [Related]

  • 25. Preferential hypermethylation of the Dickkopf-1 promoter in core-binding factor leukaemia.
    Suzuki R, Onizuka M, Kojima M, Shimada M, Fukagawa S, Tsuboi K, Kobayashi H, Shintani A, Ogawa Y, Kawada H, Hotta T, Ando K.
    Br J Haematol; 2007 Sep 15; 138(5):624-31. PubMed ID: 17686056
    [Abstract] [Full Text] [Related]

  • 26. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y, Brena RM, Hackanson B, Morrison C, Otterson GA, Plass C.
    J Natl Cancer Inst; 2006 Mar 15; 98(6):396-406. PubMed ID: 16537832
    [Abstract] [Full Text] [Related]

  • 27. Genomic variation at the MDR1 promoter and P-glycoprotein expression and activity in AML patients.
    Lourenço JJ, Maia RC, Scheiner MA, Vasconcelos FC, Moreira MA.
    Leuk Res; 2008 Jun 15; 32(6):976-9. PubMed ID: 18001833
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Methylation of p15(INK4b) and E-cadherin genes is independently correlated with poor prognosis in acute myeloid leukemia.
    Shimamoto T, Ohyashiki JH, Ohyashiki K.
    Leuk Res; 2005 Jun 15; 29(6):653-9. PubMed ID: 15863205
    [Abstract] [Full Text] [Related]

  • 30. CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia.
    Lin TC, Hou HA, Chou WC, Ou DL, Yu SL, Tien HF, Lin LI.
    Leukemia; 2011 Jan 15; 25(1):32-40. PubMed ID: 20927134
    [Abstract] [Full Text] [Related]

  • 31. ID4 methylation predicts high risk of leukemic transformation in patients with myelodysplastic syndrome.
    Wang H, Wang XQ, Xu XP, Lin GW.
    Leuk Res; 2010 May 15; 34(5):598-604. PubMed ID: 19853913
    [Abstract] [Full Text] [Related]

  • 32. Promoter hypermethylation of p15INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early-stage patients.
    Aggerholm A, Holm MS, Guldberg P, Olesen LH, Hokland P.
    Eur J Haematol; 2006 Jan 15; 76(1):23-32. PubMed ID: 16343268
    [Abstract] [Full Text] [Related]

  • 33. [Alteration of methylation status of fragile histidine triad gene promoter in patients with myelodysplastic syndrome].
    Yao DM, Qian J, Xu WR, Lin J, Jiang YW, Fei X, Han LX, Wang Y, Cen JN, Chen ZX.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb 15; 25(1):36-9. PubMed ID: 18247301
    [Abstract] [Full Text] [Related]

  • 34. GATA2 mutations are frequent in intermediate-risk karyotype AML with biallelic CEBPA mutations and are associated with favorable prognosis.
    Fasan A, Eder C, Haferlach C, Grossmann V, Kohlmann A, Dicker F, Kern W, Haferlach T, Schnittger S.
    Leukemia; 2013 Feb 15; 27(2):482-5. PubMed ID: 22814295
    [No Abstract] [Full Text] [Related]

  • 35. [Alteration of methylation status of death-associated protein kinase (dapk) gene promoter in patients with acute myeloid leukemia].
    Qian J, Yao DM, Lin J, Chen Q, Li Y, Ji RB, Yang J, Qian Z, Xiao GF, Wang YL.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec 15; 18(6):1390-4. PubMed ID: 21176336
    [Abstract] [Full Text] [Related]

  • 36. Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue: decreased p16 expression correlates with promoter methylation and poor prognosis.
    Kawaguchi K, Oda Y, Saito T, Yamamoto H, Tamiya S, Takahira T, Miyajima K, Iwamoto Y, Tsuneyoshi M.
    J Pathol; 2003 Nov 15; 201(3):487-95. PubMed ID: 14595762
    [Abstract] [Full Text] [Related]

  • 37. Aberrant expression of CKLF-like MARVEL transmembrane member 5 (CMTM5) by promoter methylation in myeloid leukemia.
    Niu J, Li H, Zhang Y, Li J, Xie M, Li L, Qin X, Qin Y, Guo X, Jiang Q, Liu Y, Chen S, Huang X, Han W, Ruan G.
    Leuk Res; 2011 Jun 15; 35(6):771-6. PubMed ID: 21168207
    [Abstract] [Full Text] [Related]

  • 38. PU.1 is regulated by NF-kappaB through a novel binding site in a 17 kb upstream enhancer element.
    Bonadies N, Neururer Ch, Steege A, Vallabhapurapu S, Pabst T, Mueller BU.
    Oncogene; 2010 Feb 18; 29(7):1062-72. PubMed ID: 19966852
    [Abstract] [Full Text] [Related]

  • 39. Methylation status of DDIT3 gene in chronic myeloid leukemia.
    Wang YL, Qian J, Lin J, Yao DM, Qian Z, Zhu ZH, Li JY.
    J Exp Clin Cancer Res; 2010 May 23; 29(1):54. PubMed ID: 20492726
    [Abstract] [Full Text] [Related]

  • 40. Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia.
    Pabst T, Eyholzer M, Haefliger S, Schardt J, Mueller BU.
    J Clin Oncol; 2008 Nov 01; 26(31):5088-93. PubMed ID: 18768433
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.